Kalow W (2008)
The relation of plasma cholinesterases to response to clinical doses of succinylcholine
Canadian Journal of Anaesthesia 55: 860

Kalow W (2004)
Atypical plasma cholinesterase. A personal discovery story: a tale of three cities
Canadian Journal of Anaesthesia 51: 206

Kalow W (2004)
Human pharmacogenomics: the development of a science
Hum Genomics 1: 375

Tang BK, Kalow W (1995)
Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4
European Journal of Clinical Pharmacology 47: 449

Kalow W (1990)
The Pennsylvania State University College of Medicine 1990 Bernard B. Brodie Lecture. Pharmacogenetics: past and future
Life Sciences 47: 1385

Kalow W (1982)
Ethnic differences in drug metabolism.
Clinical Pharmacokinetics 7: 373

Brown SS, Kalow W, Pilz W, Whittaker M, Woronick CL (1981)
The plasma cholinesteerases: a new perspective.
Advances in Clinical Chemistry 22: 1

Stewart DJ, Inaba T, Lucassen M, Kalow W (1979)
Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases
Clinical Pharmacology & Therapeutics 25: 464

Inaba T, Stewart DJ, Kalow W (1978)
Metabolism of cocaine in man
Clinical Pharmacology & Therapeutics 23: 547

Stewart DJ, Inaba T, Tang BK, Kalow W (1977)
Hydrolysis of cocaine in human plasma by cholinesterase
Life Sciences 20: 1557

Kalow W (1971)
Genetic factors in adverse drug reactions
Internationale Zeitschrift fur Klinische Pharmakologie, Therapie und Toxikologie 5: 38

Brebner J, Kalow W (1970)
Soluble esterases of human lung
Canadian Journal of Biochemistry 48: 970

Kalow W (1966)
[Pharmacogenetic problems in anesthesia].
Anaesthesist 15: 13

Simpson NE, Kalow W (1966)
Pharmacology and biological variation
Annals of the New York Academy of Sciences 134: 864

Kalow W (1965)
Contribution of hereditary factors to the response to drugs
Federation Proceedings 24: 1259

Taylor WJ, Kalow W, Sellers EA (1965)
Poisoning with organophosphorus insecticides
Canadian Medical Association Journal 93: 966

Ecobichon DJ, Kalow W (1963)
The effects of sialidase on pseudocholinesterase types
Canadian Journal of Biochemistry & Pharmacology 41: 969

Kalow W (1961)
Some properties of the soluble esterases of liver
Canadian Journal of Biochemistry & Pharmacology 39: 1329

Davies RO, Marton AV, Kalow W (1960)
The action of normal and atypical cholinesterase of human serum upon a series of esters of choline
Canadian Journal of Biochemistry & Pharmacology 38: 545

Kalow W, Gunn DR (1959)
Some statistical data on atypical cholinesterase of human serum
Annals of Human Genetics 23: 239

Kalow W, Davies R0 (1958)
The activity of various esterase inhibitors towards atypical human serum cholinesterase
Biochemical Pharmacology 1: 183

Kalow W, Genest K (1957)
A method for the detection of atypical forms of human serum cholinesterases. Determination of dibucaine numbers
Canadian Journal of Biochemistry 35: 339

Kalow W, Gunn DR (1957)
The relation between dose of succinylcholine and duration of apnea in man
Journal of Pharmacology & Experimental Therapeutics 120: 203

Kalow W, Staron N (1957)
On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers
Canadian Journal of Biochemistry 35: 1305

Kalow W, Lindsay HA (1956)
Abnormal behavior of human serum cholinesterase
Journal of Pharmacology & Experimental Therapeutics 116: 34

Kalow W, Genest K, Staron N (1956)
Kinetic studies on the hydrolyses of benzoylcholine by human serum cholinesterase
Canadian Journal of Biochemistry 34: 637

Kalow W, Lindsay HA (1955)
A comparison of optical and manometric methods for the assay of human serum cholinesterase
Canadian Journal of Biochemistry & Physiology 33: 568